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Objectives: to investigate the age-related outcome of peripheral thrombolysis and determine for which patient group this
treatment is worthwhile.
Design and methods: a combined retrospective and prospective analysis of consecutive patients undergoing thrombolysis
for acute lower-limb ischaemia was made with respect to age-related outcome and other risk factors.
Results: one hundred and two patients underwent thrombolysis for acute limb ischaemia. In the under 60 age group
there was a 40% amputation rate. Seventy-three per cent of this group smoked. In the over 80 age group, the amputation
rate was 15% and only 8% were smokers.
Conclusion: advancing age is not an adverse risk factor for thrombolysis which appears to be safe and effective in this
patient group. There is a high incidence of smoking in the younger age group (<60 years), in whom failed thrombolysis
frequently leads to amputation.
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Introduction ischaemia during the period of January 1992 to De-
cember 1994 and combined this data with a prospective
The technique of catheter embolectomy has changed analysis from January 1995 to December 1996. Patient
little since it was first described by Fogarty nearly 30 demographics, risk factors, causes of ischaemia, com-
years ago.1 This procedure remained the accepted plications and 30-day outcome were obtained from a
management for removing a clot from a patient pre- combination of hospital notes and a computer data-
senting with an acutely ischaemic limb until the more base. The distinction between primary embolism and
recent development of thrombolytic techniques. thrombosis was made on a combination of clinical,
Thrombolysis means that a large number of patients radiological and histological findings. The primary
with acute leg ischaemia can be treated in the first endpoint in reporting results is the 30-day amputation-
instance without recourse to surgery.2 There remains free survival of the patient. Secondary end points are
debate, however, as to the suitability of all patients amputation and death.
for thrombolytic therapy, particularly the elderly, who Our technique of thrombolysis is to perform a pre-
may benefit from “a quick thromboembolectomy liminary diagnostic angiogram, usually from the
under local anaesthetic”.3 contralateral common femoral artery, followed by ipsi-
This paper looks at patients treated with re- lateral antegrade puncture of the common femoral
combinant tissue plasminogen activator (rTPA) (Ac- artery and placement of an endhole 4F catheter 1cm
tilyse, Boehringer Ingelheim, Bracknell, U.K.) for acute into the thrombus in the radiology suite. A rTPA bolus
limb threatening ischaemia with respect to age-related of 3–5mg is given immediately, followed by a
outcome, other risk factors, causes of thrombosis, treat- 1–2mg/h infusion, with a simultaneous heparin in-
ment complications and 30-day outcome. fusion of 400iu/h. At 6–12h intervals, check angio-
graphy is performed to monitor progress, with catheterMethods
advancement when necessary to ensure the catheter
remains within the thrombus. Angioplasty of revealedWe have performed a retrospective analysis of all
stenoses is performed at this time. Thrombolysis ispatients who underwent thrombolysis for lower limb
continued while there is still clinical and radiological
improvement and there are no complications. Prac-*Please address all correspondence to: A. W. Lambert, Department
of Surgery, Derriford Hospital, Plymouth, PL6 8DH, U.K. tically, this occasionally means continuing for 3–5 days.
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Table 1. Risk factors and associated conditions by age for patients receiving
thrombolysis.
Age groups
<60 61–70 71–80 >80
n 15 18 30 39
Risk factors
Smoker 11 (73%) 10 (56%) 5 (17%) 3 (8%)
Hypertension 3 (20%) 6 (33%) 9 (30%) 13 (33%)
Diabetes 4 (27%) 6 (33%) 4 (13%) 5 (13%)
Associated conditions
Intermittent claudication 8 (53%) 8 (44%) 17 (57%) 17 (44%)
Coronary heart disease 6 (40%) 9 (50%) 8 (27%) 14 (36%)
Cerebrovascular disease — — 5 (17%) 6 (15%)
Table 2. Causes of acute ischaemia by age.
Age groups
Cause <60 61–70 71–80 >80
n 15 18 30 39
Thrombosis in prediseased 12 (80%) 8 (44%) 18 (60%) 22 (56%)
vessel
Graft thrombosis 1 (7%) 4 (22%) 4 (13%) 8 (21%)
Popliteal aneurysm — 1 (6%) 5 (17%) 1 (3%)
thrombosis
Embolus 2 (14%) 5 (28%) 3 (10%) 8 (21%)
Patients treated with rTPA were managed on the high are shown in Table 3. Complications of the rTPA
dependency unit. are shown in Table 4. The 10 cases of compartment
syndrome required fasciotomies but the development
of this complication did not affect patient outcome at
30 days. The minor catheter related haemorrhages
were all groin haematomas which did not require
surgical intervention, patient resuscitation or delayResults
patient discharge. Two of the major local complications
were the result of persistent haemorrhage followingOne hundred and two patients underwent throm-
catheter removal and required exploration. The thirdbolysis during the study period. There were 64 males
was a consequence of catheter removal by a dementedand 38 females of mean age 70 years (range 37–90).
elderly patient. Haemorrhage control was successfullyPatient risk factors and associated conditions are
effected by direct pressure, on recognising the prob-shown in Table 1 and the causes of thrombosis are
lem. There were five non-catheter related haem-shown in Table 2. Two female patients in the throm-
orrhages. Three were extracranial; a Mallory–Weissbosis group (ages 62 and 64 years) were taking ta-
tear following forceful vomiting, a spontaneous intra-moxifen for treatment of their breast carcinoma at the
peritoneal haemorrhage, diagnosed clinically and bytime of presentation. Patients in whom no cause for
ultrasound which was self-limiting and severe haem-the arterial thrombosis was found were screened for
aturia in a patient with carcinoma of the prostate whoarteritis and hypercoaguability states. No positive
had undergone a TURP 6 weeks previously. There wereresults were obtained.
The duration of symptoms and thrombolysis times two deaths as the result of intracranial haemorrhages
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Table 3. Duration of symptoms and thrombolysis times by age.
Age groups
<60 61–70 71–80 >80
n 15 18 30 39
Symptom duration (days) 9.7 (1–21) 9.1 (1–21) 14.3 (1–28) 9.4 (1–42)
rTPA lysis time (hours) 42.9 (14–53) 33.7 (12–48) 24.6 (14–48) 23.1 (3–48)
Table 4. Complications of peripheral rTPA by age.
Age groups
Complications <60 61–70 71–80 >80
n 15 18 30 39
Minor local haemorrhage 2 (13%) 2 (11%) 3 (10%) 7 (18%)
Major local haemorrhage — — — 3 (8%)
Non-catheter haemorrhage — — — 3 (8%)
Catheter occlusion — — 1 (3%) 1 (3%)
Early rethrombosis 5 (33%) 1 (6%) 2 (7%) 1 (3%)
Compartment syndrome 3 (13%) 3 (17%) 1 (3%) 3 (8%)
Death — — 1 (3%) 1 (3%)
Table 5. Thirty day outcome of peripheral thrombolysis age.
Age groups
Outcome <60 61–70 71–80 >80
n 15 18 30 39
Complete resolution 8 (53%) 10 (56%) 8 (27%) 18 (46%)
Partial plus angioplasty 1 (7%) 4 (22%) 9 (30%) 5 (13%)
Partial plus graft — — 7 (23%) 4 (10%)
Partial plus minor — 1 (6%) 2 (7%) —
amputation
Failed plus graft — — 1 (3%) 5 (13%)
Major amputation 6 (40%) 3 (17%) 2 (7%) 6 (15%)
Death — — 1 (3%) 1 (3%)
occurring within 24h of initiating thrombolysis. The regionally or locally. Hess described infiltration of the
intra-arterial thrombus with streptokinase from anoverall 30-day patient outcome is shown in Table 5.
endhole catheter.8 In the early 1980s he described
primary recanalisation rates of 70% in fresh embolic
occlusions, following the administration of strepto-
Discussion kinase, using this technique.9 Low dose local infusion
of rTPA has been shown to be useful in vena caval
In the 1950s, streptokinase was used for the dissolution thrombosis in children and has been advocated as a
of loculated thrombus in patients with haemothorax useful approach to reducing morbidity in this patient
or empyema. By the 1960s it was used for intravenous group.10 Early treatment with high dose intravenous
therapy and Dotter published a series in 1974 ad- rTPA has been proven to improve outcome in acute
vocating the use of smaller doses delivered directly myocardial infarction.11
into the clot.4 This was revolutionary but was not Low dose local intra-arterial infusion of rTPA is a
really taken up until the early 1980s. Later that decade, reasonably safe and effective treatment of acute limb
there was a move away from streptokinase and uro- ischaemia.12 The principle objective of therapy is to
kinase following the introduction of rTPA.5 It has remove pathological thromboemboli and facilitate res-
since been shown that rTPA is clinically superior to toration of vascular patency by rendering occluded
streptokinase6 but early work failed to prove the cost vessels patent or demonstrating underlying causal
benefit of rTPA over streptokinase, which was 10 times pathology allowing early angioplasty, stenting or sur-
more expensive at that time.7 gical revascularisation. Table 2 shows that thrombosis
of a vessel with pre-existing atheroma is the com-Thrombolytic agents can be used systemically,
Eur J Vasc Endovasc Surg Vol 17, February 1999
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Fig. 2. Thrombosis in vessels with presumed pre-existing athero-Fig. 1. Age-related incidence of smoking for patients presenting
sclerosis by age. Key as for Fig. 1.with acute thrombosis. (F) <60; (D) 61–70; (E) 71–80; (G) >80.
monest cause of acute ischaemia. An important man-
agement step following clot lysis and demonstration
of the underlying stenosis is balloon angioplasty. This
should be performed by carefully crossing the lesion
with a wire prior to angioplasty and is preferable to
the blind passage of an embolectomy catheter which
may cause an intimal dissection at the site of the
stenosis and aggravate the situation. Even if surgical
thromboembolectomy is successful, it does not im-
prove run-off. The use of intraoperative thrombolysis
following embolectomy has been advocated13 but
could be reserved for failed primary thrombolysis.
There are reports of successful limb salvage fol-
lowing pulse spray rTPA thrombolysis of 79% at 30
days and cumulative limb salvage rates of 84% at 18
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months’ follow-up.14 Conventional rTPA thrombolysis Fig. 3. Outcome of thrombolysis by age. (F) <60; (D) 61–70; (E)
reports successes of 66%.15 In our study, using these 71–80; (G) >80.
criteria, 60% of the under 60 age group and 82% of
the over 80 age group have a satisfactory outcome 2). This group also experienced the greatest percentagewith successful limb salvage. It may be that athero- of early rethrombosis, major amputation and com-sclerosis in the younger age group is a more aggressive plications following thrombolysis (Fig. 3).disease process than that seen in old age. It would In conclusion, rather than being a risky treatmentcertainly appear that smoking is related to a poor in the elderly, thrombolysis appears to be a safe andoutcome of thrombolysis. effective treatment, but in the younger age group failedIn contrast to the concerns raised by Braithwaite3 thrombolysis frequently heralds amputation.there does not appear to be any particular contra-
indications to thrombolysis with increasing age, al-
though our two deaths did occur in patients aged 78
and 82 years. Both patients were treated within 1 week References
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